Leukemia Clinical Trials in North Carolina

Showing 661-680 of 809 trials

Recruiting African American Fathers/ Sons

NCT02811848

The purpose of this study is to develop and pilot test recruitment methods for a future study of prevention of sexually transmitted infections (STI), including the human immunodeficiency virus (HIV), among Black adolescent boys through sexual health education by their fathers.

Sexually Transmitted DiseasesHIV

Duke University28 participantsStarted May 2016

Greensboro, North Carolina, United States

NO_LONGER_AVAILABLE38 miles

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

NCT02271139

This is an open-label, multicenter, single-arm, expanded access study designed to provide alectinib to participants with ALK-rearranged NSCLC after disease progression on or intolerance to prior ALK tyrosine kinase inhibitor (TKI) therapy. Participants will receive alectinib until disease progression, unacceptable toxicity, withdrawal of consent, patient or physician decision to discontinue treatment, death, alectinib becomes commercially available in the United States following approval of alectinib by the FDA, or the Sponsor decides to close the trial, whichever occurs first (approximately 15 months).

Non-Small Cell Lung Cancer

Genentech, Inc.

Bimingham, Alabama, United States • Daphne, Alabama, United States • Mobile, Alabama, United States +42 more locations

Recruiting African American Fathers/ Sons

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

Leukemia Trials in Other Cities

A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Perennial Allergic Rhinitis Study In Pediatric Subjects

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

CNDO-109-AANK for AML in First Complete Remission (CR1)

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Other Conditions in North Carolina